By Gerelyn Terzo, Global AgInvesting Media
Queensland, Australia-based livestock genetics startup Nbryo has raised A$10 million in fresh funding to fast-track the launch of its innovative bovine reproductive technologies. This capital infusion represents a pivotal move in the Brisbane company’s mission to empower beef and dairy farmers with greater returns on cattle herd genetic improvements, especially relevant as producers prioritize livestock that’s more efficient and positioned for low-emissions supply chains.
Co-led by existing backer Tenacious Ventures and new investor AgriZeroNZ of New Zealand, the round extended to Queensland Investment Corporation (QIC) joining the lineup as a fresh participant. The founding Murdoch family added further capital alongside existing private shareholders, including continued support from Mandalay Venture Partners.
Nbryo CEO Paul Niven stated, “We are grateful for the continued confidence shown by our investors, and supporter. This capital raising provides the resources we need to accelerate delivery of our technology platform and expand our impact in livestock reproduction globally.”
Proceeds will be directed toward the commercialization and expansion of its core technology, with a mission to make advanced reproductive solutions more accessible throughout the industry. In doing so, Nbryo is positioning its platform to help cattle producers and farming operations steadily lift the quality and performance of their herds over generations, while also supporting wider sustainability goals tied to efficiency and lower emissions.
This latest funding round activated the conversion of A$12.3 million in SAFE notes, buoying Nbryo’s total capital raised since last year to over $22 million and marking a milestone in its growth trajectory. Complementing this momentum, the company has attracted more than A$18 million in R&D grant funding from high-profile backers such as the Bill & Melinda Gates Foundation, Meat & Livestock Australia, and a wide array of state and federal programs, a ringing endorsement of Nbryo’s tech pipeline.
This fresh capital will enable Nbryo to accelerate the rollout of its innovative solutions, with a focus on refining its proprietary IVF platform. At its core, this platform is a blend of biology and advanced bio-digital and robotic technologies to generate superior, affordable embryos at greater scale. As a result, cattle ranchers gain access to their ideal genetics upfront, bolstering herd improvements while cutting waste throughout beef and dairy supply chains.
Development is also advancing steadily on Nbryo’s embryo transfer device, with the company on track to launch it in 2026. Together, these steps signal a growing confidence in Nbryo’s mission to revolutionize cattle reproduction by fusing biotechnology with data-driven farming. Through speedy genetic improvements, the company is poised to equip beef and dairy producers with productivity and sustainability benefits that are difficult to achieve on the same timeline with traditional breeding programs.
The content put forth by Global AgInvesting News and its parent company HighQuest Partners is intended to be used and must be used for informational purposes only. All information or other material herein is not to be construed as legal, tax, investment, financial, or other advice. Global AgInvesting and HighQuest Partners are not a fiduciary in any manner, and the reader assumes the sole responsibility of evaluating the merits and risks associated with the use of any information or other content on this site.